Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Galli

Showing results (621-630 of 758) with videos related to

Pageof 76
Sort By:
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|July 1, 1996
No evidence of a higher risk of progression to AIDS in patients with HIV-1-related severe thrombocytopeniaM Galli, M Musicco, C Gervasoni, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|July 22, 2014
Proteomics for the diagnosis of thyroid lesions: preliminary reportF Pagni, V Mainini, M Garancini, et al.
Journal of the American Veterinary Medical Association|April 2, 2011
ECG of the month. Sick sinus syndrome in a dogMaria C F Vailati, Denise S Schwartz, Nilciene M Galli, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 3, 2017
Evolution of the prevalence of hepatitis C virus infection and hepatitis C virus genotype distribution in human immunodeficiency virus-infected patients in Italy between 1997 and 2015B Rossetti, F Bai, A Tavelli, et al.
AIDS Research and Human Retroviruses|March 1, 1997
Comparable biological and molecular determinants in HIV type 1-infected long-term nonprogressors and recently infected individualsC Balotta, P Bagnarelli, C Riva, et al.
The Journal of Antimicrobial Chemotherapy|July 16, 2015
Successful pharmacogenetics-based optimization of unboosted atazanavir plasma exposure in HIV-positive patients: a randomized, controlled, pilot study (the REYAGEN study)S Bonora, S Rusconi, A Calcagno, et al.
The Pediatric Infectious Disease Journal|February 1, 1997
Plasma viremia and virus phenotype are correlates of disease progression in vertically human immunodeficiency virus type 1-infected childrenC Balotta, M C Colombo, G Colucci, et al.
AIDS (London, England)|October 9, 1998
Clinical outcome and predictive factors of failure of highly active antiretroviral therapy in antiretroviral-experienced patients in advanced stages of HIV-1 infectionA d'Arminio Monforte, L Testa, F Adorni, et al.
AIDS (London, England)|January 6, 1999
Early increase in cell-associated HIV-1 DNA in patients on highly active antiretroviral therapyM Galli, C Balotta, L Meroni, et al.
Microbial Pathogenesis|May 23, 2020
Daily consumption of a homeopathic product decreases intestinal damage and stool bacterial counts in mice challenged with Escherichia coliAntonise M Jaguezeski, Patricia Glombowsky, Gabriela M Galli, et al.
Pageof 76

Showing results (621-630 of 758) with videos related to

Sort By:
Pageof 76
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|July 1, 1996
No evidence of a higher risk of progression to AIDS in patients with HIV-1-related severe thrombocytopeniaM Galli, M Musicco, C Gervasoni, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|July 22, 2014
Proteomics for the diagnosis of thyroid lesions: preliminary reportF Pagni, V Mainini, M Garancini, et al.
Journal of the American Veterinary Medical Association|April 2, 2011
ECG of the month. Sick sinus syndrome in a dogMaria C F Vailati, Denise S Schwartz, Nilciene M Galli, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 3, 2017
Evolution of the prevalence of hepatitis C virus infection and hepatitis C virus genotype distribution in human immunodeficiency virus-infected patients in Italy between 1997 and 2015B Rossetti, F Bai, A Tavelli, et al.
AIDS Research and Human Retroviruses|March 1, 1997
Comparable biological and molecular determinants in HIV type 1-infected long-term nonprogressors and recently infected individualsC Balotta, P Bagnarelli, C Riva, et al.
The Journal of Antimicrobial Chemotherapy|July 16, 2015
Successful pharmacogenetics-based optimization of unboosted atazanavir plasma exposure in HIV-positive patients: a randomized, controlled, pilot study (the REYAGEN study)S Bonora, S Rusconi, A Calcagno, et al.
The Pediatric Infectious Disease Journal|February 1, 1997
Plasma viremia and virus phenotype are correlates of disease progression in vertically human immunodeficiency virus type 1-infected childrenC Balotta, M C Colombo, G Colucci, et al.
AIDS (London, England)|October 9, 1998
Clinical outcome and predictive factors of failure of highly active antiretroviral therapy in antiretroviral-experienced patients in advanced stages of HIV-1 infectionA d'Arminio Monforte, L Testa, F Adorni, et al.
AIDS (London, England)|January 6, 1999
Early increase in cell-associated HIV-1 DNA in patients on highly active antiretroviral therapyM Galli, C Balotta, L Meroni, et al.
Microbial Pathogenesis|May 23, 2020
Daily consumption of a homeopathic product decreases intestinal damage and stool bacterial counts in mice challenged with Escherichia coliAntonise M Jaguezeski, Patricia Glombowsky, Gabriela M Galli, et al.
Pageof 76